J7677 is a valid 2023 HCPCS Code that could be used to indicate Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram for reimbursement purposes.
J7677 belongs to Medical Care Type of Service and has been in effect since Jul 01, 2019.
Revefenacin inh non-com 1mcg
J7677 code information
| HCPCS code: | J7677 |
| Description: | REVEFENACIN INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, 1 MICROGRAM |
| Effective Date: | Jul 01, 2019 |
| Added Date: | Jul 01, 2019 |
| Termination Date: | HCPCS J7677 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | D1G - |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J7677